Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-28

Clinical Trial Update: Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ciprofloxacin 0.3% with dexamethasone 0.1% for acute otitis externa; results completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ciprofloxacin 0.3% (ciprofloxacin)
  • dexamethasone 0.1% (dexamethasone)

Snippet

Sponsor: Exela Pharma Sciences, LLC. | Conditions: Acute Otitis Externa | Phase 3 | Status: COMPLETED | Results posted: 2021-05-28